ABUS

#2549
Arbutus Biopharma Corporation Common Stock
4.49 USD
+3.22%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
4.46
4.54
Rango anual
2.94
5.10
Cambio diario
+3.22%
Variación mensual
+4.42%
Variación en los últimos 6 meses
-0.22%
Cambio anual
+41.64%
Cierres anteriores
4.35
Abrir
4.51
Bid
Ask
Mínimo
4.46
High
4.54
Volumen
188
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Noticias